Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
BLOOD (2012)
期刊
BLOOD
卷 120, 期 26, 页码 5185-5187出版社
AMER SOC HEMATOLOGY
关键词
类别
资金
- Interdisciplinary Center for Clinical Research of Wurzburg University (IZKF)
- Early Clinical Trial Unit of the Comprehensive Cancer Center Mainfranken
作者
我是这篇论文的作者
推荐
Has MRD graduated from its adolescence in ALL?
Matthew D. Seftel
BLOOD (2021)
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy P. Delbrook, Maryalice Stetler-Stevenson, Terry J. Fry, David F. Stroncek, Crystal L. Mackall
JOURNAL OF CLINICAL ONCOLOGY (2021)
Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman, Nicola Goekbuget, Ralf C. Bargou, Yi Zeng, Gerhard Zugmaier, Franco Locatelli
THERAPEUTIC ADVANCES IN HEMATOLOGY (2023)
Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation
Emily C. Liang, Simone E. Dekker, Jean M. G. Sabile, Stefan Torelli, Amy Zhang, Katharine Miller, Parveen Shiraz, Brandon Hayes-Lattin, Jessica T. Leonard, Lori Muf
BLOOD ADVANCES (2023)
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Kristen Fousek, Junji Watanabe, Sujith K. Joseph, Ann George, Xingyue An, Tiara T. Byrd, Jessica S. Morris, Annie Luong, Melisa A. Martinez-Paniagua, Khaled Sanber, Shoba A. Navai, Ahmed Z. Gad, Vita S. Salsman, Pretty R. Mathew, Hye Na Kim, Dimitrios L. Wagner, Lorenzo Brunetti, Albert Jang, Matthew L. Baker, Navin Varadarajan, Meenakshi Hegde, Yong-Mi Kim, Nora Heisterkamp, Hisham Abdel-Azim, Nabil Ahmed
LEUKEMIA (2021)
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
Manuel Behmueller, Nikolaos Tselis, Nikolaos Zamboglou, Eleni Zoga, Dimos Baltas, Claus Roedel, Georgios Chatzikonstantinou
FRONTIERS IN ONCOLOGY (2021)
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study
Shigeki Hirabayashi, Tadakazu Kondo, Satoshi Nishiwaki, Shuichi Mizuta, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Ryota Imanaka, Satoshi Takahashi, Jun Ishikawa, Shingo Yano, Hirohisa Nakamae, Tetsuya Eto, Takafumi Kimura, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Patterns of disease relapse and posttreatment follow-up of patients with resected pancreatic adenocarcinoma: A single-center analysis
Beatriz A. Gonzales, Alessandro L. Diniz, Silvio M. Torres, Heber Salvador de Castro Ribeiro, Igor Correia de Farias, Andre Luis de Godoy, Felipe J. F. Coimbra, Victor H. Fonseca de Jesus
JOURNAL OF SURGICAL ONCOLOGY (2022)
Blinatumomab Conundrum in Low-Risk Relapsed B-Cell ALL
Luke D. Maese, Michael A. Pulsipher
JOURNAL OF CLINICAL ONCOLOGY (2023)
Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations
Xinnan Li, Xiuling Miao, Yaming Wang, Junzhao Sun, Haifeng Gao, Jing Han, Yuxin Li, Qingjun Wang, Chenjing Sun, Jianguo Liu
FRONTIERS IN IMMUNOLOGY (2022)
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL
Matthew Greenwood, Toby Trahair, Rosemary Sutton, Michael Osborn, John Kwan, Sally Mapp, Rebecca Howman, Antoinette Anazodo, Brenton Wylie, James D'Rozario, Mark Hertzberg, Ian Irving, David Yeung, Luke Coyle, Amanda Jager, Dan Engeler, Nicola Venn, Chris Frampton, Andrew H. Wei, Kenneth Bradstock, Luciano Dalla-Pozza
BLOOD ADVANCES (2021)
How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL
Regina M. Myers, Nirali N. Shah, Michael A. Pulsipher
BLOOD (2023)
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
Elias Jabbour, Koji Sasaki, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Joseph D. Khoury, Rashmi Kanagal-Shamanna, Jeffrey Jorgensen, Issa F. Khouri, Partow Kebriaei, Nitin Jain, Yesid Alvarado, Tapan M. Kadia, Shilpa Paul, Guillermo Garcia-Manero, Bouthaina S. Dabaja, Jan A. Burger, Courtney D. DiNardo, Naval A. Daver, Guillermo Montalban-Bravo, Musa Yilmaz, Maro Ohanian, Alessandra Ferrajoli, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Susan O'Brien, Hagop M. Kantarjian
CANCER (2021)
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation
Alexandre Pellan Cheng, Matthew Pellan Cheng, Conor James Loy, Joan Sesing Lenz, Kaiwen Chen, Sami Smalling, Philip Burnham, Kaitlyn Marie Timblin, Jose Luis Orejas, Emily Silverman, Paz Polak, Francisco M. Marty, Jerome Ritz, Iwijn De Vlaminck
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Miriam Mozaffari Jovein, Gabriele Ihorst, Jesus Duque-Afonso, Ralph Waesch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Juergen Finke, Florian Scherer
BLOOD CANCER JOURNAL (2023)
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V. Wenge, Klaus Wethmar, Corinna A. Klar, Hedwig Kolve, Tim Sauer, Linus Angenendt, Georg Evers, Simon Call, Andrea Kerkhoff, Cyrus Khandanpour, Torsten Kessler, Rolf Mesters, Christoph Schliemann, Jan-Henrik Mikesch, Christian Reicherts, Monika Brueggemann, Wolfgang E. Berdel, Georg Lenz, Matthias Stelljes
CANCERS (2022)
Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
Michaela Kotrova, Johannes Koopmann, Heiko Trautmann, Nael Alakel, Joachim Beck, Kathrin Nachtkamp, Bjorn Steffen, Simon Raffel, Andreas Viardot, Klaus Wethmar, Nikos Darzentas, Claudia D. Baldus, Nicola Goekbuget, Monika Brueggemann
BLOOD ADVANCES (2022)
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
Marina Y. Konopleva, Christoph Roellig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Juergen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas A. Schaefer, Oliver Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Recher, Rebeca Rodriguez-Veiga, David Taussig, Norbert Vey, Sung-Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M. Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H. Wei
BLOOD ADVANCES (2022)
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia
Claudia Chiriches, Dilawar Khan, Maria Wieske, Nathalie Guillen, Michal Rokicki, Carol Guy, Marieangela Wilson, Kate J. Heesom, Oliver Gerhard Ottmann, Martin Ruthardt
ANNALS OF HEMATOLOGY (2022)
A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia using Droplet Digital PCR
Claudia Schwinghammer, Johannes Koopmann, Guranda Chitadze, Leonid Karawajew, Monika Brueggemann, Cornelia Eckert
JOURNAL OF MOLECULAR DIAGNOSTICS (2022)
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display
Steffen Krohn, Ammelie Svea Boje, Carina Lynn Gehlert, Sebastian Lutz, Nikos Darzentas, Henrik Knecht, Dietrich Herrmann, Monika Brueggemann, Axel J. Scheidig, Katja Weisel, Martin Gramatzki, Matthias Peipp, Katja Klausz
FRONTIERS IN IMMUNOLOGY (2022)
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
Merle Sauer, Joerg Scheffel, Stefan Frischbutter, Niklas Mahnke, Marcus Maurer, Thomas Burmeister, Karoline Krause, Martin Metz
FRONTIERS IN IMMUNOLOGY (2022)
Therapy-Related AML: Clinical/Biological Features and Long-Term Outcome in a Cohort of 1133 Adult AML Patients
Sophia Gross, Jana Ihlow, Leonie Busack, Kacper Adamiak, Jens F. Schrezenmeier, Julia Jesse, Michaela Schwarz, Anne Floercken, Kathrin Rieger, Jan Kronke, Philipp le Coutre, Vivien Boldt, Ann-Christin Von Bruenneck, David Horst, Thomas Burmeister, Igor Wolfgang Blau, Ulrich Keller, Lars Bullinger, Joerg Westermann
BLOOD (2022)
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
Sven Liebig, Martin Neumann, Patricia Silva, Jutta Ortiz-Tanchez, Veronika Schulze, Konstandina Isaakidis, Cornelia Schlee, Michael P. Schroeder, Thomas Beder, Luc G. T. Morris, Timothy A. Chan, Lorenz Bastian, Thomas Burmeister, Stefan Schwartz, Nicola Goekbuget, Liliana H. Mochmann, Claudia D. Baldus
SCIENTIFIC REPORTS (2023)
The KMT2A recombinome of acute leukemias in 2023
C. Meyer, P. Larghero, B. Almeida Lopes, T. Burmeister, D. Groeger, R. Sutton, N. C. Venn, G. Cazzaniga, L. Corral Abascal, G. Tsaur, L. Fechina, M. Emerenciano, M. S. Pombo-de-Oliveira, T. Lund-Aho, T. Lundan, M. Montonen, V. Juvonen, J. Zuna, J. Trka, P. Ballerini, H. Lapillonne, V. H. J. van der Velden, E. Sonneveld, E. Delabesse, R. R. C. de Matos, M. L. M. Silva, S. Bomken, K. Katsibardi, M. Keernik, N. Grardel, J. Mason, R. Price, J. Kim, C. Eckert, L. Lo Nigro, C. Bueno, P. Menendez, U. zur Stadt, P. Gameiro, L. Sedek, T. Szczepanski, A. Bidet, V. Marcu, K. Shichrur, S. Izraeli, H. O. Madsen, B. W. Schaefer, S. Kubetzko, R. Kim, E. Clappier, H. Trautmann, M. Brueggemann, P. Archer, J. Hancock, J. Alten, A. Moericke, M. Stanulla, J. Lentes, A. K. Bergmann, S. Strehl, S. Koehrer, K. Nebral, M. N. Dworzak, O. A. Haas, C. Arfeuille, A. Caye-Eude, H. Cave, R. Marschalek
LEUKEMIA (2023)
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
Michael J. Mauro, Timothy P. Hughes, Dong-Wook Kim, Delphine Rea, Jorge E. Cortes, Andreas Hochhaus, Koji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Michael C. Heinrich, Valle Gomez-Garcia de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J. W. M. Janssen, Michael Deininger, Naranie Shanmuganathan, Mark B. Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
LEUKEMIA (2023)
Variable outcomes of hepatitis E infections in patients with hemato-oncologic diseases
Viktoria Ingwersen, Joerg Hofmann, Marion Muche, Philipp Le Coutre, Thomas Schneider, Corinna Leng, Thomas Burmeister, Georg Maschmeyer, Ulrich Keller, Stefan Schwartz
ONCOLOGY RESEARCH AND TREATMENT (2023)
Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
Thomas Burmeister, Daniela Groeger, Nicola Goekbuget, Bernd Spriewald, Michael Starck, Ahmet Elmaagacli, Dieter Hoelzer, Ulrich Keller, Stefan Schwartz
SCIENTIFIC REPORTS (2023)
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular Analysis
Thomas Burmeister, Lars Bullinger, Philipp le Coutre
ACTA HAEMATOLOGICA (2023)
Structure and content of the EU-IVDR Current status and implications for pathology
Andy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, Carolin Ploeger, Daniel Kazdal, Roland Penzel, Jan Budczies, Gisela Kempny, Marlon Kazmierczak, Christa Flechtenmacher, Gustavo Baretton, Wilko Weichert, David Horst, Frederick Klauschen, Ulrich M. Gassner, Monika Brueggemann, Michael Vogeser, Peter Schirmacher, Albrecht Stenzinger
PATHOLOGIE (2023)